Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

New ACR Open Rheumatology Journal Delivers Science to Wide Audience

Susan Bernstein  |  Issue: September 2019  |  September 17, 2019

  • “Anti-Retinoblastoma Protein Antibodies: A New Specificity in Systemic Lupus Erythematosus Associated with Protection Against Lupus Nephritis,” a study by researchers at Johns Hopkins University that found anti-Rb antibodies, a novel biomarker in lupus, may define a subset of patients protected from kidney involvement and are not associated with antiphospholipid antibodies.3 Anti-retinoblastoma antibodies were present in 15 of 222 lupus patients in the cohort, were strongly negatively associated with proteinuria, renal involvement and anemia, and were positively associated with stroke.
  • “Reduced Ovarian Function in Female Rheumatoid Arthritis Patients Trying to Conceive,” a study from The Netherlands, found that women in the cohort with rheuma­toid arthritis had lower levels of serum anti‐Müllerian hormone (AMH), a useful proxy for ovarian function.4 AMH levels were lowest in anti-citrullinated protein antibody-positive patients. Preconception AMH levels were not associated with time to pregnancy in the rheumatoid arthritis patients compared with healthy controls.

ACROR articles will be indexed by PubMed after its first 25 articles are published and PubMed approval is received. When indexed in PubMed, the journal will have an impact factor, which will expand visibility for authors, including those from the initial 25 articles.

“We would like to publish more basic science and translational science, but we are seeing submissions across the full range of rheumatology research,” says Dr. Yelin. “We have left the peak, but the snowball has not yet reached its full velocity. But we are on our way.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Susan Bernstein is a freelance journalist based in Atlanta.

References

  1. Piwowar H, Priem J, Lariviere V, et al. The state of OA: A large-scale analysis of the prevalence and impact of Open Access articles. PeerJ. 2018 Feb 13;6:e4375.
  2. Katz P, Yelin E. Opening salvo. ACR Open Rheumatology. 2019 Mar 15;1(1):3.
  3. Goules A, Li J, Antiochos B, et al. Anti-retinoblastoma protein antibodies: A new specificity in systemic lupus erythematosus associated with protection against lupus nephritis. ACR Open Rheumatology. 2019 Jun 6;1(5):287–291.
  4. Brouwer J, Dolhain RJEM, Hazes JMW, et al. Reduced ovarian function in female rheumatoid arthritis patients trying to conceive. ACR Open Rheumatology. 2019 Jul 4;1(5):327–335.

Page: 1 2 3 | Single Page
Share: 

Filed under:From the CollegeResearch Rheum Tagged with:ACR Open RheumatologyDr. Edward H. YelinDr. Patricia P. Katzopen accessResearch

Related Articles

    ACR Open Rheumatology Seeks New Editors

    April 8, 2023

    As ACR Open Rheumatology (ACROR) enters its fifth year, its founding editors in chief are looking back on the journal’s accomplishments and forward to ushering in a new era, beginning with a search for their successors. Patricia Katz, PhD, professor of medicine and health policy at the University of California, San Francisco (UCSF), and Edward…

    The ACR Debuts Open Access Journal

    November 19, 2018

    The ACR will add a new professional journal, ACR Open Rheumatology, in January 2019. An open access journal, it will feature the same high-quality, rigorously peer-reviewed articles on original investigations in rheumatology research, as well as commentaries and reviews, as the ACR’s other journals, Arthritis & Rheumatology (A&R) and Arthritis Care & Research (AC&R). Co-Editors-in-Chief…

    Arthritis Care & Research Celebrates 25 Years

    June 1, 2013

    From its beginnings as a quarterly journal in 1988, to a successful monthly publication today, AC&R has evolved and thrived

    New Studies Examine Impact of Poverty, Race, Ethnicity in Patients with SLE

    October 17, 2017

    To correctly address a problem, one must have a handle on its nuances—a clear understanding of what is linked and how. And thus far, when it comes to lupus, we haven’t reached the point of understanding those intricacies. Things are heading in the right direction, however, with two new studies that get us much closer…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences